| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K49290616 |
| PharmacoGx | BRD-K49290616 |
| Database | Identifier |
|---|---|
| Smiles: | OC[C@@H]1O[C@@H](CC(=O)NCc2ccncn2)CC[C@H]1NC(=O)c1ccc(F)cc1 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MYOCD | CTRPv2 | pan-cancer | AAC | 0.16 | 0.05 |
| mRNA | CD69 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.05 |
| mRNA | MRPS15 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.05 |
| mRNA | GLS | CTRPv2 | pan-cancer | AAC | 0.16 | 0.05 |
| mRNA | CTXN1 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.05 |
| mRNA | GMIP | CTRPv2 | pan-cancer | AAC | 0.18 | 0.05 |
| mRNA | C14orf166 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.05 |
| mRNA | CAMK2A | CTRPv2 | pan-cancer | AAC | 0.15 | 0.05 |
| mRNA | CC2D2A | CTRPv2 | pan-cancer | AAC | -0.17 | 0.05 |
| mRNA | AKR1C3 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.05 |
